CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Bronchoscopic mucosal biopsyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04904939
NCT04904939N/ACompleted
CompareCT.gov

Endobronchial Mucosal Biopsy in Patients With Suspected Pulmonary Sarcoidosis

Alexandria University·interventional·Posted May 27, 2021·Updated May 27, 2021

In Brief

A clinical study evaluating Bronchoscopic mucosal biopsy for Endobronchial Mucosal Pathology in Pulmonary Sarcoidosis. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This prospective interventional study was done between May and September 2020. We included 20 patients from the chest department, Alexandria Main University Hospital (AMUH) with the inclusion criteria of having suspected pulmonary sarcoidosis (based on clinical and radiological presentation) and being ≥18 years of age. The bronchoscopy procedure was done under local anesthesia. Endobronchial biopsies and bronchoalveolar lavage were obtained.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEndobronchial Mucosal Pathology in Pulmonary Sarcoidosis
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMay 27, 2021
Enrollment StartMay 15, 2020
Primary CompletionSep 1, 2020
Study CompletionSep 28, 2020
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 5.1 years ago

Interventions

Bronchoscopic mucosal biopsyprocedure

Endobronchial forceps biopsy using flexible bronchoscope